Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Schwab, Claire, Nebral, Karin, Chilton, Lucy, Leschi, Cristina, Waanders, Esmé, Boer, Judith M., Žaliová, Markéta, Sutton, Rosemary, Öfverholm, Ingegerd Ivanov, Ohki, Kentaro, Yamashita, Yuka, Groeneveld-Krentz, Stefanie, Froňková, Eva, Bakkus, Marleen, Tchinda, Joelle, Barbosa, Thayana da Conceição, Fazio, Grazia, Mlynarski, Wojciech, Pastorczak, Agata, Cazzaniga, Giovanni, Pombo-de-Oliveira, Maria S., Trka, Jan, Kirschner-Schwabe, Renate, Imamura, Toshihiko, Barbany, Gisela, Stanulla, Martin, Attarbaschi, Andishe, Panzer-Grümayer, Renate, Kuiper, Roland P., den Boer, Monique L., Cavé, Hélène, Moorman, Anthony V., Harrison, Christine J., Strehl, Sabine
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Stimulus Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728462/
https://ncbi.nlm.nih.gov/pubmed/29296789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017006734
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados